News

Highlights and publications from Frontage’s experts

NEWS
Frontage Acquires Nucro-Technics Inc. and Nucro-Technics Holdings, Inc.

Frontage Acquires Nucro-Technics Inc. and Nucro-Technics Holdings, Inc.

See More Info
NEWS
Frontage Receives Multiple 2023 CRO Leadership Awards

Frontage Receives Multiple 2023 CRO Leadership Awards

See More Info
NEWS
Frontage welcomes Dr. John Kapeghian as the Senior Vice President of Global Safety & Toxicology

Frontage welcomes Dr. John Kapeghian as the Senior Vice President of Global Safety & Toxicology

See More Info
NEWS
Frontage welcomes Dr. James Huang as VP of Corporate Quality Assurance

Frontage welcomes Dr. James Huang as VP of Corporate Quality Assurance

See More Info
NEWS
Stewart Jacobson, DVM, DACVP joins Frontage as Vice President, Pathology Services

Stewart Jacobson, DVM, DACVP joins Frontage as Vice President, Pathology Services

See More Info
NEWS

Frontage Announces CEO and President Promotions

See More Info
NEWS

Frontage Partners with Eisai and Biogen to Complete the Clarity AD study for the Alzheimer’s Drug, Lecanemab

See More Info
NEWS
Stephen Gacheru PhD. joins Frontage as Vice President, Cell and Gene Therapy Operations

Stephen Gacheru PhD. joins Frontage as Vice President, Cell and Gene Therapy Operations

See More Info
NEWS
James Houston joins Frontage as Vice President of Information Technology

James Houston joins Frontage as Vice President of Information Technology

See More Info